Fundz

Aerska Raises $39M Series A Financing led by EQT Dementia Fund and age1 to deliver RNA Medicines to the Brain.

PRIVATEFeb 09, 2026

Amount Raised

$39 Million

Round Type

Series A

DublinBiotechnologyHealth CareMedicalTherapeutics

Investors

IASO VenturesEQT Dementia FundAge1

Description

Aerska, a biotechnology company, announced the close of a $39 million Series A financing led by EQT Dementia Fund and age1. The funding will be used to advance its brain shuttle technology for treating neurological diseases. This brings total funds raised to $60 million. Aerska's platform aims for effective RNAi therapeutics delivery across the blood-brain barrier.

Quick answer

Aerska raised $39 Million in a Series A round, dated February 9, 2026. Investors: IASO Ventures, EQT Dementia Fund and Age1. Aerska is based in Dublin, Dublin, Ireland.

How much did Aerska raise?
Aerska raised $39 Million in a Series A round on February 9, 2026.
Who invested in Aerska?
IASO Ventures, EQT Dementia Fund and Age1 are named as investors in this round.
What does Aerska do?
Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain.
Where is Aerska based and how big is it?
Aerska is based in Dublin, Dublin, Ireland. Fundz records about 20 employees.
Who are the decision-makers at Aerska?
Fundz holds 2 contacts at Aerska, including the CEO, Co-founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Aerska that raised within 45 days of this round, from Fundz verified event records.

  • Diamyd Medical raised $125M (Funding Round) on March 23, 2026.
  • Combat Medical raised $3.5M (Series A) on March 12, 2026.
  • NexCure raised $19M (Series A) on March 5, 2026.
  • Cognito Therapeutics raised $105M (Series C) on March 5, 2026.
  • Polares Medical SA raised $50M (Series C) on March 3, 2026.
  • Faeth Therapeutics raised $200M (Post-IPO Equity) on February 18, 2026.

Who to call at Aerska, and when

A new round usually means Aerska is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aerska raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aerska, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aerska. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aerska

Location

Dublin, Dublin, Ireland

About

Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain. The company is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS. Aerska is headquartered in Dublin, Ireland, with research operations in London, UK.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aerska raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJack O., CEO, Co-founder hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aerska's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Aerska raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.